WHO reports new case of MERS-CoV in Saudi Arabia, risk ‘moderate’
The WHO has been notified of a human case of Middle East Respiratory coronavirus (MERS-CoV) in the Kingdom of Saudi Arabia.
Drugs
Health
Pharma
Drugs
Health
Medical
Lilly to invest $4.5 billion to build Medicine Foundry in Indiana state, US
Eli Lilly and Company will build a $4.5 billion center for advanced manufacturing and drug development in Indiana to innovate new production methods.
Drugs
Health
Pharma
Amplifica’s human trial medicine for hair growth shows 15% more efficacy
Amplifica Holdings Group Inc.’s first-in-human trial of an injectable medicine for treating hair loss has shown a more than 15% increase in non-vellus.
Drugs
Health
Pharma
Brazil becomes 20th WHO-validated nation to eliminate lymphatic filariasis
Brazil became the 20th country in the world that has been validated by WHO to have eliminated lymphatic filariasis as a public health.
Drugs
Health
Pharma
J&J to build $2b facility in North Carolina to make future products
HQ Team October 2, 2024: Johnson & Johnson will invest $2 billion to build a biologics manufacturing facility in Wilson, North Carolina, anticipating.
Climate
Health
Pharma
ADNOC to buy Germany’s chemical producer Covestro for $13 billion
The Abu Dhabi National Oil Company, ADNOC, the state-owned oil company of the United Arab Emirates, will buy Germany’s chemicals maker Covestro AG.
Drugs
Health
Pharma
AstraZeneca, Daiichi’s Enhertu drug gets FDA’s priority review in US
AstraZeneca and Daiichi Sankyo got a priority review from the Food and Drug Administration for their Enhertu drug to treat a form of.
Drugs
Health
Pharma
Marburg virus disease kills 8 people in Rwanda, 26 others confirmed
Eight people have died in Rwanda due to Marburg virus disease and 26 others were confirmed to be infected by the illness —.
Drugs
Health
Pharma
Kezar Life Sciences halts mid-stage lupus nephritis trial after four people die
Kezar Life Sciences Inc., a US-based biotechnology company, has stopped a trial in patients with a type of kidney disease after four people.
Drugs
Health
Pharma
Roche arm to buy breast cancer portfolio from Regor for $850 million
Genentech, a member of the Roche Group, will acquire a portfolio of CDK inhibitors to treat breast cancer from Regor Pharmaceuticals for an.